Profit-hungry pharma sees some biotechs as ripe for the picking.
Willyard
Cassandra
C
D001688:Biological Products / Q000191:economics; D001709:Biotechnology / Q000191:economics* / Q000639:trends; D004345:Drug Industry / Q000191:economics*; D007182:Income; D006113:United Kingdom; D014481:United States
D001688:Biological Products